# SK biopharmaceuticals

> SK biopharmaceuticals is a VC fund in Seongnam backing Health Care and Manufacturing. See 1 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Seongnam, South Korea
- Total investments: 1
- Last investment: May 2026
- Lead investor: 0%
- Last updated: Aug 2026
- Website: http://skbp.com

SK biopharmaceuticals is a VC fund in Seongnam focused on Health Care and Manufacturing. SK biopharmaceuticals aims to become a top tier specialty pharmaceutical company with global new drugs & innovative pipeline in CNS / metabolic disorders and to provide world class specialized pharmaceutical manufacturing services.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 1 | 100% |
| Manufacturing | 1 | 100% |
| Pharmaceutical | 1 | 100% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Full-Life Technologies | Full-Life Technologies Limited (“Full-Life”) is a fully integrated global RadioTherapeutics company headquartered in Shanghai, China with operations in Europe. | $109M | Series D | May 18, 2026 |  |

1 of 1 investments shown.

## Co-investors
- [Chengwei Capital](https://shizune.co/investors/profile/chengwei-capital) — VC Fund, 1 deal together
- [HSG](https://shizune.co/investors/profile/hsg-cap) — VC Fund, 1 deal together
- [Junson Capital](https://shizune.co/investors/profile/junson-capital) — VC Fund, 1 deal together
- [Plaisance Capital Management](https://shizune.co/investors/profile/plaisance-capital-management) — VC Fund, 1 deal together
- [Sky9 Capital](https://shizune.co/investors/profile/sky9-capital) — VC Fund, 1 deal together
- [TSG Capital](https://shizune.co/investors/profile/tsg-85fb) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Sigma Partners](https://shizune.co/investors/profile/sigma-partners) — VC Fund
- [EDBI](https://shizune.co/investors/profile/edbi) — VC Fund
- [Trifecta Capital Advisors](https://shizune.co/investors/profile/trifecta-capital-advisors) — VC Fund

## FAQ

### What does SK biopharmaceuticals invest in?

SK biopharmaceuticals invests primarily in Health Care, Manufacturing and Pharmaceutical startups, most often at Series D stage. Most of the 1 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did SK biopharmaceuticals last invest?

The most recent investment recorded for SK biopharmaceuticals closed in May 2026. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co